Physician

Holly A Sanders, MD

According to 2025 Medicare claims, Holly Sanders, MD (NPI: 1356556187) practices dermatology in the Johnson City, TN market, with the plurality of this provider's patient population coming from Washington, TN. This provider's primary affiliated billing organization is DERMATOLOGY ASSOCIATES, P.C. (NPI: 1487695862; TIN: 62-1013399) and primary practice location at 37615-8002.

Sanders' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,053 traditional Medicare patients, billed 4,964 HCPCS/CPT codes, and received $213,024 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,084 prescription claims across 873 beneficiaries totaling $658,633 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 1 records totaling $16. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $325,665 to $213,024. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $192,744 to $658,633. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$163K$326K2015 Medicare payment: $325,665 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $304,798 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $319,446 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $281,498 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $279,281 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $217,397 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $255,618 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $181,887 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $208,314 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $213,024 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,7628,859$325,665
20161,8308,171$304,798
20171,9687,520$319,446
20181,6196,216$281,498
20191,5606,226$279,281
20201,3035,058$217,397
20211,3455,510$255,618
20221,0483,878$181,887
20231,0084,818$208,314
20241,0534,964$213,024

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$329K$659K2015 Drug cost: $192,744 (USD; Tot_Drug_Cst)2016 Drug cost: $271,741 (USD; Tot_Drug_Cst)2017 Drug cost: $321,605 (USD; Tot_Drug_Cst)2018 Drug cost: $179,235 (USD; Tot_Drug_Cst)2019 Drug cost: $139,045 (USD; Tot_Drug_Cst)2020 Drug cost: $190,070 (USD; Tot_Drug_Cst)2021 Drug cost: $375,296 (USD; Tot_Drug_Cst)2022 Drug cost: $332,737 (USD; Tot_Drug_Cst)2023 Drug cost: $357,969 (USD; Tot_Drug_Cst)2024 Drug cost: $658,633 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157971,753$192,744
20168621,933$271,741
20179982,488$321,605
20188081,986$179,235
20197411,845$139,045
20208311,969$190,070
20218391,957$375,296
20227281,569$332,737
20238141,894$357,969
20248732,084$658,633

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths385449$72
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more774954$57
11102Biopsy of related skin growth, first growth261296$56
17000Destruction of precancer skin growth, 1 growth344403$31
88305Pathology examination of tissue using a microscope, intermediate complexity384681$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab411,095$160,734
OtezlaApremilast13450$81,815
FluorouracilFluorouracil1664,862$13,442
Clobetasol PropionateClobetasol Propionate1464,611$8,043
AcitretinAcitretin22660$6,672

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$16ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Holly A. Sanders, MD?

Tedicare shows public-source Medicare data for Holly A. Sanders, MD (NPI 1356556187), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Holly A. Sanders, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Holly A. Sanders, MD?

Holly A. Sanders, MD is linked to DERMATOLOGY ASSOCIATES, P.C. (billing NPI 1487695862) in the available physician profile data.

Does Holly A. Sanders, MD have Open Payments data?

Holly A. Sanders, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.